Health Care [ 12/12 ] | Health Care Equipment & Supplies [ 44/74 ]
NASDAQ | Common Stock
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye.
The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists.
The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally.
STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 7, 24 | 0.36 Increased by +168.26% | 0.24 Increased by +50.00% |
| Jul 31, 24 | -0.05 Decreased by -116.67% | 0.24 Decreased by -120.83% |
| May 7, 24 | -0.05 Decreased by -116.67% | 0.05 Decreased by -200.00% |
| Feb 26, 24 | 0.13 Increased by +8.33% | 0.17 Decreased by -23.53% |
| Feb 27, 24 | 0.13 Increased by +11.83% | 0.17 Decreased by -19.16% |
| Nov 1, 23 | 0.30 Increased by +500.00% | 0.18 Increased by +66.67% |
| Nov 1, 23 | 0.30 Increased by +500.00% | 0.18 Increased by +66.67% |
| Aug 2, 23 | 0.12 Increased by 0.00% | 0.19 Decreased by -36.84% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | 88.59 M Increased by +16.15% | 9.98 M Increased by +28.67% | Increased by +11.27% Increased by +10.78% |
| Jun 30, 24 | 99.00 M Increased by +29.80% | 7.38 M Decreased by -4.86% | Increased by +7.45% Decreased by -26.71% |
| Apr 30, 24 | 77.36 M Decreased by -3.68% | -3.34 M Decreased by -169.32% | Decreased by -4.32% Decreased by -171.96% |
| Mar 31, 24 | 77.36 M Decreased by -3.68% | -3.34 M Decreased by -169.32% | Decreased by -4.32% Decreased by -171.96% |
| Jan 31, 24 | 76.27 M Decreased by -17.37% | 7.76 M Increased by +27.90% | Increased by +10.17% Increased by +54.79% |
| Dec 31, 23 | 76.27 M Decreased by -17.37% | 7.76 M Increased by +27.90% | Increased by +10.17% Increased by +54.79% |
| Oct 31, 23 | 80.31 M Increased by +9.22% | 4.82 M Increased by +77.75% | Increased by +6.00% Increased by +62.74% |
| Sep 30, 23 | 80.31 M Increased by +9.22% | 4.82 M Increased by +77.75% | Increased by +6.00% Increased by +62.74% |